The memory-care unit wants to calm Mom down with a pill. Before you say yes, there's something they may have skipped.

“WELTRUZA offers the proven efficacy of olanzapine in an innovative long-acting subcutaneous injectable, helping to fill a ...

New research links repeated gabapentin use with increased risk, prompting cautious monitoring for gabapentin and dementia ...

AXSM's Auvelity sales surged 54.2% to $333 million in the first half of 2026. New indications could further expand its growth potential.

(DKart/iStockphoto/Getty Images) A little-known treatment for heart failure, developed more than half a century ago and ...

Recent research has shown that hormone therapy may help improve mood changes and brain fog that are often associated with ...

WELTRUZA ™ (olanzapine) for extended-release injectable suspension is the first and only once-monthly subcutaneous long-acting injectable (LAI) ...

Spread the loveImagine a world where an Alzheimer’s diagnosis doesn’t automatically mean an inevitable, rapid decline.

Biogen's Q3 earnings are due Oct 28. Explore FY2026 EPS guidance, Alzheimer’s revenue growth, and key risk/reward ...

The Food and Drug Administration (FDA) recently approved a first-of-its-kind medication for treating Parkinson’s disease. Patients take JUVMO daily, a prescription medication that mimics the effects ...

A Michigan family’s dispute over sedating medications highlights the risks, challenges, and difficult care decisions ...